ILA — Island Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Island Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	4.79	2	1.66	7.25	12.9
Net Total Accounts Receivable
Net Total Receivables	0.021	0.017	0.891	0.18	0.286
Prepaid Expenses
Total Current Assets	4.9	2.05	2.56	7.49	13.3
Net Goodwill
Total Assets	4.9	2.05	2.56	7.49	14
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.581	0.264	1.05	0.336	0.539
Total Long Term Debt
Total Debt
Total Liabilities	0.581	0.264	1.05	0.336	0.539
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	4.32	1.79	1.52	7.16	13.5
Total Liabilities & Shareholders' Equity	4.9	2.05	2.56	7.49	14
Total Common Shares Outstanding